Loss of Regulator of G Protein Signaling 5 Exacerbates Obesity, Hepatic Steatosis, Inflammation and Insulin Resistance by Deng, Wei et al.
Loss of Regulator of G Protein Signaling 5 Exacerbates
Obesity, Hepatic Steatosis, Inflammation and Insulin
Resistance
Wei Deng
., Xinan Wang
., Jinfeng Xiao, Kuoju Chen, Heng Zhou, Difei Shen, Hongliang Li, Qizhu Tang*
Department of Cardiology, Cardiovascular Research Institute, Wuhan University, Renmin Hospital, Wuhan, China
Abstract
Background: The effect of regulator of G protein signaling 5 (RGS5) on cardiac hypertrophy, atherosclerosis and
angiogenesis has been well demonstrated, but the role in the development of obesity and insulin resistance remains
completely unknown. We determined the effect of RGS5 deficiency on obesity, hepatic steatosis, inflammation and insulin
resistance in mice fed either a normal-chow diet (NC) or a high-fat diet (HF).
Methodology/Principal Findings: Male, 8-week-old RGS5 knockout (KO) and littermate control mice were fed an NC or an
HF for 24 weeks and were phenotyped accordingly. RGS5 KO mice exhibited increased obesity, fat mass and ectopic lipid
deposition in the liver compared with littermate control mice, regardless of diet. When fed an HF, RGS5 KO mice had a
markedly exacerbated metabolic dysfunction and inflammatory state in the blood serum. Meanwhile, macrophage
recruitment and inflammation were increased and these increases were associated with the significant activation of JNK,
IkBa and NF-kBp65 in the adipose tissue, liver and skeletal muscle of RGS5 KO mice fed an HF relative to control mice. These
exacerbated metabolic dysfunction and inflammation are accompanied with decreased systemic insulin sensitivity in the
adipose tissue, liver and skeletal muscle of RGS5 KO mice, reflected by weakened Akt/GSK3b phosphorylation.
Conclusions/Significance: Our data suggest that loss of RGS5 exacerbates HF-induced obesity, hepatic steatosis,
inflammation and insulin resistance.
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Introduction
Obesity has reached epidemic proportions not only in Western
societies but also in China. It is closely associated with an increase
in diseases such as type 2 diabetes, cardiovascular disease and
nonalcoholic hepatic steatosis [1,2,3,4]. Hence, understanding the
biological basis of obesity-related pathologies, including insulin
resistance, dyslipidemia and hyperglycemia, and discovering new
therapeutic strategies to restore metabolic function are urgent
goals for the biomedical community.
Guanine nucleotide binding proteins (G proteins), including
Gai, Gas and Gaq family members, are activated by G protein-
coupled receptors (GPCRs) signaling from outside of the cell
membrane and regulate downstream effectors, such as adenylyl
cyclases, phospholipase C, ion channels and cGMP phosphodies-
terase [5]. G proteins have been implicated in the regulation of
body weight and endocrine/metabolic function, such as the G
protein subunit Gai2 deficiency in adipose tissue and liver of mice
produced hyperinsulinemia, impaired glucose tolerance and
resistance to insulin, and mice expressing activated Gas in fat
tissue, liver and skeletal muscle displayed normal body mass but
blunted glucose metabolism [6,7].
Regulators of G protein signaling (RGS) proteins are negative
regulators of G protein-mediated signaling and act as GTPase
accelerating proteins for heterotrimeric G proteins. The effect of
downregulating total RGS proteins in obesity has been studied,
demonstrating a block in weight gain and insulin resistance in
homozygous Gai2G184S knock-in male mice, which express
RGS-insensitive Gai2 with a G184S mutation that blocks RGS
protein binding and GTPase acceleration, fed an HF [8]. Mice
without RGS2, which is known to limit signals mediated via Gas-
and Gaq-coupled GPCRs, exhibited greatly reduced fat deposits,
decreased serum lipids, low leptin levels, improved glucose
clearance and insulin sensitivity [9]. Functional diversity may
exist among RGS proteins and RGS5 is an important member of
the RGS protein superfamily that has recently been reported to
regulate cardiac hypertrophy, atherosclerosis and angiogenesis
through the inhibition of several Gai- and Gaq-mediated signaling
pathways [10,11,12,13]. However, the role of RGS5 in obesity
and associated metabolic disorders is not clear.
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30256We hypothesized that the absence of RGS5 should modify the
development of obesity and alter metabolic state during an HF
and used RGS5 knockout (KO) and wild-type (WT) mice to
demonstrate this hypothesis. This study is the first to clarify the
role of RGS5 in obesity-associated metabolic dysfunction and
insulin sensitivity.
Materials and Methods
Mouse experiments
All animal procedures were performed in accordance with the
Guide for the Care and Use of Laboratory Animals, published by
the US National Institutes of Health (NIH Publication No. 85-23,
revised 1996) and were approved by the Institutional Animal Care
and Use Committee at Renmin Hospital of Wuhan University,
China (protocol 00012012).
RGS5 KO mice on a C57BL/6 background were generated by
methods described previously [10]. Male RGS5 KO mice and
their C57BL/6 littermates were exposed to a 12-h light/12-h dark
schedule and maintained at a constant temperature of 22uC. Prior
to 8 weeks of age, all mice were fed standard laboratory chow and
water ad libitum, and then mice were randomly allocated to either
a normal chow (10 kcal% fat, D12450B, Research Diets) or a
high-fat diet (60 kcal% fat, D12492, Research Diets) for 24 weeks.
In this study, all investigations were completed in a fasted state,
with food removed for 6 hours (from 8AM to 2PM) and free access
to water. Feed consumption was measured weekly, and body
weight and plasma glucose were measured every four weeks. Blood
samples were collected via a retro-orbital bleed every eight weeks,
and epididymal adipose, liver and gastrocnemius muscle samples
were harvested after 24 weeks of diet. All blood and tissue samples
for biochemical analysis were stored at 280uC.
Plasma determinations
Plasma glucose was determined using a glucometer via tail vein
blood sampling (OneTouch UltraEasy, LifeScan). Blood insulin,
lipid and adipokines were measured by ELISA.
Glucose tolerance tests (GTT) and insulin tolerance tests
(ITT)
Mice were fasted for 6 hours with free access to water and
subsequently received an intraperitoneal injection of glucose
( 1g / k g ;S i g m a - A l d r i c hC o . ,S t .L o u i s ,M O ,U S A )o ri n s u l i n
(0.75 units/kg; Novolin R, Novo Nordisk Co., Bagsvaerd,
Denmark). Blood samples were taken from the tail vein prior to
injection and at 15, 30, 60 and 120 minutes after injection.
Blood glucose was determined using a glucometer, as described
above.
Histological analysis and morphometry
A portion of epididymal adipose tissue and liver was fixed
overnight in 10% formalin, dehydrated in an ethanol bath, and
paraffin-embedded. Sections were cut and then stained with
hematoxylin-eosin for the observation of adipose and liver tissue
structure (BX51, Olympus). A portion of Liver was frozen
sectioned and stained for Oil Red O. Single adipocyte was
measured using an image quantitative digital analysis system
(Image-Pro plus 6.0); one hundred adipocytes in the epididymal
adipose tissue were measured in each group.
RNA extractions and real-time PCR
Total RNA was isolated using the TRIzol reagent (Invitro-
gen) from various organs, and quantitative RT-PCR analysis
was performed using the LightCycler 480 SYBR Green 1
Master Mix (Roche) and the LightCycler 480 QPCR System
(Roche). Target gene mRNA expression was normalized to the
internal control b- a c t i na n de x p r e s s e dr e l a t i v et ot h ec o n t r o l
group.
Western blot analysis
Protein samples denatured in SDS sample buffer (125 mmol/l
Tris-HCl, pH 6.8, 50% glycerol, 2% SDS, 5% mercaptoethanol,
and 0.01% bromophenol blue) were subjected to SDS-PAGE and
blotted onto Immobilon-FL transfer membrane (Millipore).
Blotted membranes were blocked with 5% skim milk in Tris-
buffered saline containing 0.1% Tween 20 for 2 hours and were
subsequently incubated with primary antibodies against JNK, NF-
kBp65, IkBa, Akt, GSK3b, phospho-JNK (Thr183/Tyr185),
phospho-IkBa (Ser32/36), phospho-NF-kBp65 (Ser536), phos-
pho-Akt (Ser473) and phospho-GSK3b (Ser9) proteins (Cell
Signaling) overnight at 4uC. After three washes in Tris-buffered
saline containing 0.1% Tween 20, the membranes were incubated
with anti-mouse or anti-rabbit IgG for 1 hour. Quantification of
Table 1. Effect of RGS5 deficiency on body weight at initial of feeding and body weight, mean food intake, fat and liver weight
after 24 weeks of feeding (n=8–10).
Variable NC HFD
WT KO WT KO
Body weight (initial) (g) 23.8260.19 24.4160.32 24.7460.32 24.3960.31
Body weight (24 weeks) (g) 31.8660.57 38.3360.83## 45.2461.11## 50.2860.99**
Visceral fat weight (g) 1.2460.09 3.1060.24## 3.6860.18## 4.9760.27**
% Body weight 3.8960.27 8.0360.49## 8.1060.22## 9.8960.49*
Liver weight (g) 1.3460.04 1.6460.08## 1.8760.11## 2.5460.09**
% Body weight 4.2060.11 4.3060.22 4.1260.19 5.0560.17**
Food intake(kcal/mice/week) 72.6262.81 85.6363.45## 88.5463.42## 95.9063.73
Data are means 6 SEM.
##p,0.01 vs. WT mice fed an NC;
*p,0.05 and
**p,0.01 vs. WT mice fed an HF.
doi:10.1371/journal.pone.0030256.t001
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system (Li-Cor Biosciences) to detect protein expression. The
specific protein expression levels were normalized to GAPDH for
the total cell lysate.
Statistics
Data are expressed as means 6 SEM. Differences among
groups were determined by two-way ANOVA followed by a
Tukey’s post-hoc test. Comparisons between two groups were
Figure 1. Effect of RGS5 deficiency on body weight, fat mass and adipocyte size. A Representative photograph of WT and KO mice fed an
NC and HF for 24 weeks. B Growth curves of WT (black) and KO (blank) mice fed an NC (triangle) and an HF (rhombus) (n=8–11). C Histology of
visceral adipose tissue with hematoxylin-eosin. D Mean adipocyte size of the visceral adipose tissue in WT (black) and KO (blank) mice fed an NC and
an HF for 24 weeks (n=5). E Expression levels of mRNA related to adipogenesis in the visceral fat of WT (a dotted line at value 1) and KO (black) mice
fed an HF for 24 weeks (n=6). Values represent means 6 SEM. #p,0.05 and ##p,0.01 compared with WT mice fed an NC; *p,0.05 and **p,0.01
compared with WT mice fed an HF.
doi:10.1371/journal.pone.0030256.g001
Loss of RGS5 Exacerbates Obesity and IR
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30256performed using an unpaired Student’s t-test. A value of p,0.05
was considered significant.
Results
RGS5 deficiency markedly increased body weight, fat
mass and adipocyte size
The initial weights of mice ranged from 23.5 to 25.0 g with no
difference among the groups (Table 1). First, we demonstrated that
RGS5 KO mice experienced an increase in body mass relative to
littermate controls during the feeding period from 4 to 24 weeks
with an HF and from 8 to 24 weeks with an NC; these body mass
increases were associated with an increase in food intake (Fig. 1A,
B and Table 1). Additionally, the RGS5 KO mice had significantly
increased fat mass and liver weight at 24 weeks of feeding (Table 1).
The quantity of visceral adipose tissue is the major driver of
adipose tissue function, and two factors contribute to fat
deposition: the increased size of existing adipocytes because of
fat accumulation and the formation of new adipocytes through
adipogenesis [14]. To determine whether the increase in fat mass
was due to increased adipocyte cell size and/or number, we
assessed both and focused on the expression of key genes
associated with adipogenesis in epididymal adipose tissue of mice
fed an HF. RGS5 KO mice displayed hypertrophic adipocytes
relative to the controls (Fig. 1C, D). There was reduced expression
of several anti-adipogenic factors, such as Preadipocyte factor-1
(Pref-1) and cyclin D1, and markedly elevated expression of
adipogenesis genes, including PPARc, Cluster of differentiation 36
(CD36) and Fatty acid-binding protein 4 (FABP4), in the fat of KO
mice compared with that of their controls; however, there was no
difference in CCAAT/enhancer-binding protein a (C/EBPa)
expression between the two groups (Fig. 1E). The expression of
Diacylglycerol acyltransferase 1 (DGAT1), DGAT2 and Glycerol-
3- phosphate acyltransferase 1 (GPAT1) was elevated or exhibited
a higher tendency; however, in contrast with lipogenesis, the
expression levels of the rate-limiting enzymes of lipolysis, Adipose
triglyceride lipase (ATGL) and Hormone-sensitive lipase (HSL),
were decreased in the adipose tissue of KO mice (Fig. 1E).
RGS5 deficiency exacerbated metabolic dysfunction and
inflammation in serum
We investigated whether blood glucose, blood insulin, circulat-
ing metabolism and inflammation state in obese mice were
exacerbated by RGS5 deletion. Although there was no difference
in fasting glucose levels, RGS5 KO mice fed an HF exhibited a
markedly unremitting elevation in plasma insulin compared with
the control mice fed an HF (Fig. 2A, B). At initial of feeding, the
markers of inflammation and lipid profiles were no difference
among the groups except FFA (Table 2); However, after 24 weeks
of feeding, fasting plasma triacylglycerol, cholesterol and LDL
levels were significantly higher in RGS5 KO mice than in WT
mice fed an HF but were not distinguishable between genotypes in
mice fed an NC (Table 3). Fasting plasma FFA levels were
markedly higher and HDL levels were lower in RGS5 KO mice
Figure 2. RGS5 deficiency exacerbated hyperinsulinemia. A The
level of fasting blood glucose in WT (black) and KO (blank) mice fed an
NC (triangle) and HF (rhombus) from 0 to 24 weeks (n=8–11). B,C The
level of plasma insulin in WT (black) and KO (blank) mice fed an
NC(triangle) and HF (rhombus) from 0 to 24 weeks (B) and
corresponding AUC (C) (n=8). Values represent means 6 SEM.
#p,0.05 and ##p,0.01 compared with WT mice fed an NC;
*p,0.05 and **p,0.01 compared with WT mice fed an HF.
doi:10.1371/journal.pone.0030256.g002
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and resistin levels were increased and adiponectin levels were
lower in RGS5 KO mice compared with littermate controls fed an
HF, whereas these levels were not distinguishable between
genotypes in mice fed an NC (Table 3). Circulating inflammatory
factors, including IL-1b, IL-2, IL-6, TNFa and MCP-1, were
elevated in RGS5 KO mice fed an HF compared with controls
(Table 3).
RGS5 deficiency exacerbated hepatic steatosis
Next, we tested the association between increased liver weight
and hepatic steatosis. Histological analysis revealed that RGS5
KO mice showed a significantly increased accumulation of
hepatic lipid droplets, as compared with WT littermates (Fig. 3A,
B ) .W h e nf e da nH F ,t h el e v e l so ft h em R N A sf o rP P A R c and
Sterol regulatory element-binding protein 1c (SREBP-1c),
transcription factors that regulate the expression of genes
Table 2. Metabolic and inflammatory variables in circulation at initial of feeding (n=8).
Variable NC HFD
WT KO WT KO
FFA (mmol/l) 0.7060.03 0.9360.04## 0.7760.04 0.9560.04**
TG (mg/dl) 38.9361.92 41.5061.73 36.4861.46 40.9361.71
TC (mg/dl) 129.4066.99 133.8165.63 133.1165.77 135.2165.69
HDL (mg/dl) 94.5663.34 98.5264.14 98.4064.90 97.2464.09
LDL (mg/dl) 17.6760.64 19.3060.80 17.6760.53 19.5160.80
leptin (pg/ml) 4185.086133.44 4272.406179.24 4062.636179.68 4261.146180.03
resistin (pg/ml) 878.84642.93 901.80637.38 779.53629.21 887.01637.42
Adiponectin (ug/ml/g) 1.1860.06 1.3160.05 1.1760.05 1.2760.05
IL-1b (pg/ml) 37.1661.60 42.4061.77 40.1861.65 40.8361.68
IL-2 (pg/ml) 11.6260.63 10.8060.44 10.9860.52 11.3160.45
IL-6 (pg/ml) 0.6760.03 0.7160.03 0.7060.03 0.6760.02
TNF-a (pg/ml) 2.2160.10 2.1460.09 2.3360.08 2.2560.08
MCP-1 (pg/ml) 21.2460.66 23.1060.96 23.0661.03 22.7260.93
Data are means 6 SEM.
##p,0.01 vs. WT mice fed an NC;
**p,0.01 vs. WT mice fed an HF.
doi:10.1371/journal.pone.0030256.t002
Table 3. Metabolic and inflammatory variables in circulation after 24 weeks of feeding (n=8).
Variable NC HFD
WT KO WT KO
FFA (mmol/l) 0.7760.03 0.9460.03## 1.1260.05## 1.5560.05**
TG (mg/dl) 41.3561.72 44.6061.86 50.5462.10## 64.1962.69**
TC (mg/dl) 135.3065.69 145.1966.08 255.19610.76## 342.35614.12**
HDL (mg/dl) 89.5063.75 74.7263.12## 74.2063.11## 55.2362.30**
LDL (mg/dl) 17.9360.72 19.1860.80 24.5361.00## 32.8861.33**
leptin (pg/ml) 5351.956225.92 5531.806233.29 12442.906525.18## 16355.706690.77**
resistin (pg/ml) 922.48638.68 971.84640.81 1310.94654.49## 1552.38665.34**
Adiponectin (ug/ml/g) 1.1360.04 1.0260.04# 0.5760.02## 0.3460.01**
IL-1b (pg/ml) 39.9661.63 44.5261.86 57.8862.27## 69.8662.86**
IL-2 (pg/ml) 13.9560.55 14.6160.40 17.2960.72## 19.1960.79*
IL-6 (pg/ml) 0.7360.02 0.9260.04## 1.2160.03## 1.6660.07**
TNF-a (pg/ml) 2.8860.10 2.7660.10 3.6660.12## 5.1360.21**
MCP-1 (pg/ml) 24.2160.99 22.5560.70 29.6861.17## 39.5961.65**
Data are means 6 SEM.
#p,0.05 and
##p,0.01 vs. WT mice fed an NC;
*p,0.05 and
**p,0.01 vs. WT mice fed an HF.
doi:10.1371/journal.pone.0030256.t003
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livers of RGS5 KO mice, with no changes in the expression
levels of Acetyl-CoA carboxylase a (ACCa) and Stearoyl-CoA
desaturase 1 (SCD1) and decreased expression levels of Fatty
acid synthetase (FASN) (Fig. 3C). The expression level of
Carnitine palmitoyltransferase- 1a (CPT-1a), which is involved
in fatty acid oxidation, was not affected by RGS5 deletion,
whereas Acyl-CoA oxidase 1 (ACOX1) and Long-chain acyl-
CoA dehydrogenase (LCAD) were decreased in RGS5 KO
obese mice (Fig. 3C).
RGS5 deficiency increased fatty acid oxidation in adipose
tissue and skeletal muscle
To investigate whether the energy consumption state is
influenced by RGS5 deletion in obese mice, we also examined
related enzymes associated with fatty acid oxidation in the
epididymal adipose tissue and gastrocnemius muscle. We observed
that the mRNA levels of PPARa and the PPARa-regulated genes
CPT-1a, ACOX1, LCAD, Uncoupling protein 2 (UCP2) and
UCP3 were elevated or exhibited an increasing trend in the
adipose tissue, as well the mRNA expression of PPARa, CPT-1a,
ACOX1, LCAD and UCP3 were markedly increased in the
skeletal muscle (Fig. 4A, B).
RGS5 deficiency was associated with increased
macrophage recruitment and inflammation in adipose
tissue, liver and skeletal muscle
Inflammation is a key component of obesity-associated insulin
resistance. To examine the association of the Rgs5 gene and
inflammation with obesity, we investigated the gene expression of
inflammatory mediators in major insulin-responsive tissues of mice
fed an HF. We found that the expression levels of F4/80, which is
a specific marker of mature macrophages, and TNFa were
significantly elevated in the epididymal adipose, liver and skeletal
muscle of KO mice compared with those of WT mice (Fig. 5A, B,
C). The levels of IL-1b, IL-6 and MCP-1 mRNA were increased in
the adipose and skeletal muscle (Fig. 5A, B, C). These results
implied an increase in the recruitment of macrophages and the
infiltration of inflammation into these tissues of KO mice. JNK
and NF-kB play pivotal roles in inflammation induced by obesity,
Figure 3. RGS5 deficiency exacerbated fat accumulation in liver. A Histology of liver with hematoxylin-eosin. B Histology of liver with oil red
O. C Expression levels of mRNA related to fatty acid metabolism in the liver of WT (a dotted line at value 1) and KO (black) mice fed an HF for 24
weeks (n=6). Values represent means 6 SEM. *p,0.05 and **p,0.01 compared with WT mice.
doi:10.1371/journal.pone.0030256.g003
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kB. In accordance with the presence of these elevated inflamma-
tory mediators, we observed elevated phosphorylation levels of
JNK, IkBa and NF-kBp65 proteins in the adipose tissue, liver and
skeletal muscle of RGS5 KO mice (Fig. 5D, E).
RGS5 deficiency produced decreased peripheral insulin
sensitivity
Type 2 diabetes is caused by a combination of insulin
resistance in the adipose tissue, liver and skeletal muscle and
impaired insulin secretion from the pancreatic islets [15]. Next,
we determined whether RGS5 plays a role in mediating obesity-
induced insulin resistance. Following 24 weeks of feeding, RGS5
KO mice showed a significant impairment of glucose tolerance
compared with the control mice, regardless of diet; furthermore,
the glucose AUC during GTT was increased (Fig. 6A, B, C).
Additionally, glucose concentrations after insulin challenge and
the glucose AUC during ITT were increased by both NC and HF
treatment (Fig. 6D, E, F). The phosphorylated levels of Akt/
GSK3b, critical molecules in the insulin signaling pathway, were
reduced in the visceral adipose tissue, liver and gastrocnemius
muscle of RGS5 KO mice compared with the control mice fed an
HF (Fig. 6G, H).
Discussion
Abnormal lipid metabolism and inflammation are widely
recognized as the most important factors in the etiology of
obesity-induced whole-body insulin resistance and metabolic
diseases. The present study used a diet-induced obesity paradigm
with RGS5 KO and WT mice. The major findings are as follows:
(i) RGS5 deletion increases dyslipidemia, obesity, adipose tissue
deposition, hepatic steatosis and circulating inflammation; (ii)
RGS5 deletion exacerbates inflammation and activates the JNK
and NF-kB inflammatory signaling pathways in the adipose tissue,
liver and skeletal muscle when mice are fed an HF; (iii) RGS5
deficiency results in decreased systemic insulin sensitivity accom-
panied by weakened Akt/GSK3b signaling in the adipose tissue,
liver and skeletal muscle when mice are fed an HF. These findings
demonstrate that RGS5 plays a novel and indispensable role in
regulating obesity and insulin sensitivity.
Many Gai- coupled receptors have the anti-lipolytic ability
through Gai-protein mediated inhibition of adenylyl cyclase
activation and cAMP accumulation in adipose tissue and elevated
cAMP level can increase lipolysis [16,17]. RGS5 deficiency would
likely involve enhanced Gai-mediated signal pathway and be in
charge of increased lipogenesis (mediated by DGAT1, DGAT2
and GPAT1) and decreased lipolysis (mediated by HSL and
ATGL), under the conditions of hyperinsulinemia and high FFA,
which can induce adipocyte hypertrophy [18,19,20]. The high
FFA concentration may result from an impaired buffering capacity
for lipid storage in the postprandial state due to the consequent
prolonged absorption time rather than the increased fasting
adipocyte lipolysis when RGS5 KO mice are compared with
controls [21]. In addition, increased adiposity is often character-
istic of an increase in the number of adipocytes. Accordingly,
RGS5 deletion suppressed the expression of anti-adipogenic
factors, such as Pref-1 and cyclin D1. Pref-1, which is expressed
in preadipocytes, is an inhibitor of adipocyte differentiation, and
its overexpression can exhibit a resistance to HF-induced obesity
in mice [22,23]. Cyclin D1 inhibits adipocyte differentiation
through repression of PPARc function [24]. Furthermore,
elevated expression levels of PPARc and its target genes, CD36
and FABP4, were also observed in KO mice with an HF. PPARc
is the most important gene involved in adipocyte terminal
differentiation and survival. CD36 and FABP4 exhibit terminal
differentiation gene expression and participate in lipid accumula-
tion [25,26]. Overall, our results suggest that loss of RGS5
increases fat deposit in adipose tissue and body weight through
promoting adipocyte differentiation and hypertrophy.
High circulating FFA and hyperinsulinemia induced by
peripheral insulin resistance can accelerate ectopic fat deposition
in the liver by increasing the delivery of FFA or stimulating de
novo lipogenesis via PPARc and SREBP-1c, which are the key
regulators of fatty acid synthesis and hepatic steatosis [27,28].
Conversely, liver fat content correlates with hepatic insulin
resistance, and decreasing the hepatic lipid concentration can
improve insulin sensitivity [29,30,31]. Under conditions of high
circulating FFA and hyperinsulinemia, RGS5 deletion in obese
mice significantly promoted the activation of PPARc and SREBP-
1c and led to exacerbated phenotypes, including increased liver
weight and enhanced lipid droplet accumulation.
Chronic low-grade inflammation and macrophage activation are
hallmarks of obesity and insulin resistance. Compared with WT
Figure 4. RGS5 deficiency increased fatty acid oxidation in the
adipose tissue and skeletal muscle of mice fed an HF for 24
weeks. A Expression levels of mRNA related to fatty acid oxidation in
the visceral adipose tissue of WT (a dotted line at value 1) and KO
(black) mice (n=6). B Expression levels of mRNA related to fatty acid
oxidation in the gastrocnemius muscle of WT (a dotted line at value 1)
and KO (black) mice (n=6). Values represent means 6 SEM. *p,0.05
and **p,0.01 compared with WT mice.
doi:10.1371/journal.pone.0030256.g004
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adipose tissue; this F4/80 expression implied exacerbated macro-
phage infiltration, which is thought to be the main source of locally
produced proinflammatory adipokines [32,33]. Furthermore, in the
fat of RGS5 KO mice, we observed an increased expression of
MCP-1, which can recruit macrophages into adipose tissue [34,35].
AlongwithMCP-1andF4/80,weobservedhigherexpressionlevels
of proinflammatory cytokines, such as IL-1b, IL-6 and TNFa,
which areactively secreted by macrophagesor adipocytes and cause
insulin resistance [36,37]. In addition to the local inflammation in
adipose tissue induced by obesity, increased inflammatory factor
secretion into the circulation from fat can influence other insulin
target organs, such as skeletal muscle and liver.
Skeletal muscle is a major target of insulin, and its insulin
sensitivity plays an important role in energy intake and utilization.
HF-induced insulin resistance is due, in part, to increases in
macrophage infiltration and the local levels of TNFa and IL-6 in
skeletal muscle and the subsequent deleterious effects of these
cytokines on insulin signaling in muscle tissue [38,39]. The
expression levels of inflammatory mediators, including IL-1b, IL-
6, TNFa, MCP-1 and F4/80, are significantly elevated in the
skeletal muscle of KO mice fed an HF. We also observed higher
level of TNFa and F4/80 expression in the liver. In contrast to
adipose tissue, the liver undergoes an obesity-induced activation of
inflammation mainly within cells of the liver, including the resident
macrophage-like Kupffer cells that crucially affect insulin sensitiv-
ity [40,41]. TNFa can induce hepatic lipogenesis and increase
hepatic triglyceride production and TNFa deficiency protected
from HF-induced hepatic steatosis and insulin resistance [42,43].
Furthermore, RGS5 deletion increased the activation of both the
JNK and NF-kB pathways in the adipose tissue, liver and skeletal
muscle of obese mice, which are the two critical signaling
pathways of inflammation induced by obesity [44].
N o t a b l y ,c o m p a r e dw i t hl e a na n i m a l s , the excess of visceral adipose
tissue and hypertrophic adipocytes in obese animals led to an increased
release of adipokines, except for adiponectin, into the circulation that
may be responsible for metabolic dysfunction and insulin resistance in
peripheral organs, including liver and skeletal muscle [45,46,47].
RGS5 deletion exacerbated the pathological secretion of leptin, resistin
and adiponectin from adipose tissue in obese mice.
Few studies were reported to explore the exact mechanism of
RGS proteins on insulin signaling except for some researches
described the phenotype of body weight and insulin sensitivity and
explained the potential reasons through GPCRs and G proteins
[8,9]. Gai2 and Gaq/11 are positive regulator of insulin action,
including insulin-stimulated tyrosine phosphorylation of insulin-
receptor (IR) and IR substrate 1(IRS1) and subsequent glucose
uptake [6,48,49,50]. However, it is well known that obese animals
generally exhibit a decrease in insulin sensitivity whereas lower
body weight is often accompanied by increased insulin action. So it
is not surprising that the RGS5 KO mice showed weakened
insulin sensitivity because obesity and obesity associated higher
Figure 5. RGS5 deficiency promoted inflammation and JNK, NF-kB signaling in the adipose tissue, liver and skeletal muscle of mice
fed an HF for 24 weeks. A Expression levels of mRNA related to inflammation in the visceral adipose tissue of WT (a dotted line at value 1) and KO
(black) mice (n=6). B Expression levels of mRNA related to inflammation in the liver of WT (a dotted line at value 1) and KO (black) mice(n=6). C
Expression levels of mRNA related to inflammation in the gastrocnemius muscle of WT (a dotted line at value 1) and KO (black) mice (n=6). D
Phosphorylation levels of proteins related to inflammatory signaling in the visceral adipose tissue, liver and gastrocnemius muscle of KO and WT mice
(n=6). E Quantitative measurements of p-JNK, p-IkBa and p-NF-kBp65 protein relative to their total protein between WT mice (a dotted line at value
1) and KO mice (black). Values represent means 6 SEM. *p,0.05 and **p,0.01 compared with WT mice.
doi:10.1371/journal.pone.0030256.g005
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PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e30256levels of lipids and inflammation in circulation and tissues can
directly and indirectly destroy insulin signaling in multiple sites [2].
Although the present results clearly indicate RGS5 is an
important protein in obesity and insulin resistance and also point
to several possible mechanisms, there are some questions remain
unknown and require further study, especially the reasons of
increased food intake and energy consumption. Obesity is the
result of an imbalance between energy intake and energy
consumption. Although fatty acid oxidation is strengthened in
insulin-sensitive organs, including adipose tissue and skeletal
muscle in KO mice fed an HF, increased obesity and body weight
maybe associated with the increased food intake induced by RGS5
deletion. G protein-mediated signaling pathways involve in
regulating general behavioral functions and metabolic processes
through GPCRs which widespread distribute in the body. In the
neurons of hypothalamus and brain stem, a variety of GPCRs,
including the melanocortins system, the NPY receptors, the
cannabinoid system, the ghrelin system, the monoamine GPCRs,
orexin system and the galanin receptors, can recognize neuropep-
tides and neurotransmitters to regulate food intake and metabolic
rate [51]. RGS5 is ubiquitous in peripheral tissues and also present
in brain [52]. It is not known whether this phenotype is due to the
lack of expression of RGS5 in peripheral tissues or in the central
nervous system, but as the function of RGS5, enhanced Gai- and
Gaq-mediated signaling pathways might contribute to the model
we observed. In addition, Cho H showed that RGS5 deficiency
resulted in a lean phenotype [53]. Although we can not determine
the exact reasons for the discrepancies between Cho’s study and
ours, the phenotype of obesity in RGS5 KO mice are evident in
our experiment and KO mice exhibited an increased body weight
through increasing calorie intake, promoting adipocyte differen-
tiation and hypertrophy in the adipose tissue and accelerating
ectopic fat deposition in the liver. Our observation may be
confirmed indirectly by Caroline’s research for RGS2 [9]. RGS2 is
unique among RGS proteins and limits signals mediated via Gas-
or Gaq- but not Gai-coupled GPCRs. RGS2 KO mice exhibited
a resistant to age-related or high-fat induced body weight gain,
impaired adipocyte differentiation and hypertrophy comparing
with WT littermates.
In summary, the present study reveals that genetic deletion of
RGS5 leads to decreased insulin sensitivity induced by a high-fat
diet as well as obesity, severe hepatic steatosis and inflammation,
which are associated with activation of inflammatory signaling in
the adipose tissue, liver and Skeletal muscle. Our findings the first
demonstrate that RGS5 plays a critical role in the metabolic
regulation of the body and maybe an important treatment target
to obesity in the future.
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